• Western blot analysis of various lysates using KLHL7 Rabbit polyclonal antibody (STJ117840) at 1:3000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) (STJS000856) at 1:10000 dilution. Lysates/proteins: 25 Mu g per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 10s.

Anti-KLHL7 antibody (200-300) (STJ117840)

SKU:
STJ117840

Shipping:
Free Shipping
Current Stock:
Host: Rabbit
Applications: WB
Reactivity: Human/Mouse
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-KLHL7 (200-300) is suitable for use in Western Blot research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: PBS with 0.01% Thimerosal, 50% Glycerol, pH7.3.
Purification: Affinity purification
Dilution Range: WB 1:1000-1:5000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: KLHL7
Gene ID: 55975
Uniprot ID: KLHL7_HUMAN
Immunogen Region: 200-300
Immunogen: A synthetic peptide corresponding to a sequence within amino acids 200-300 of human KLHL7 (NP_061334.4).
Immunogen Sequence: QAEPLIQDNPECLKMVISGM RYHLLSPEDREELVDGTRPR RKKHDYRIALFGGSQPQSCR YFNPKDYSWTDIRCPFEKRR DAACVFWDNVVYILGGSQLF P
Tissue Specificity Widely expressed, with highest levels in adult and fetal heart, CNS and adult testis.
Function Substrate-specific adapter of a BCR (BTB-CUL3-RBX1) E3 ubiquitin ligase complex. The BCR(KLHL7) complex acts by mediating ubiquitination and subsequent degradation of substrate proteins. Probably mediates 'Lys-48'-linked ubiquitination.
Protein Name Kelch-Like Protein 7
Cellular Localisation Nucleus
Cytoplasm
Colocalizes With Cul3 In Punctate Structures At The Perinuclear Region Of The Cytoplasm
Alternative Antibody Names Anti-Kelch-Like Protein 7 antibody
Anti-KLHL7 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance